SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue for the quarter ended September 2023 remained nearly unchanged at Rs. 5453.00 millions.Net Profit witnessed a 141.16% growth almost the double from Rs. 156.70 millions to Rs. 377.90  millions  of same quarter last year.OP of the company witnessed a marginal growth to 712.10 millions from 367.30 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 5453.00 5414.10 0.72 11084.80 11064.20 0.19 22171.10 21840.20 1.52
Other Income 71.10 50.60 40.51 141.70 102.10 38.79 255.70 320.40 -20.19
PBIDT 712.10 367.30 93.87 1511.30 979.00 54.37 2520.90 2883.20 -12.57
Interest 44.40 35.10 26.50 83.90 68.90 21.77 164.70 82.90 98.67
PBDT 667.70 332.20 100.99 1427.40 910.10 56.84 2356.20 2661.00 -11.45
Depreciation 156.70 113.20 38.43 301.10 223.00 35.02 461.30 432.60 6.63
PBT 511.00 219.00 133.33 1126.30 687.10 63.92 1894.90 2228.40 -14.97
TAX 133.10 62.30 113.64 286.30 181.50 57.74 495.10 571.80 -13.41
Deferred Tax 22.00 5.40 307.41 29.20 3.00 873.33 32.50 1.70 1811.76
PAT 377.90 156.70 141.16 840.00 505.60 66.14 1399.80 1656.60 -15.50
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 13.06 6.78 92.49 13.63 8.85 54.08 11.37 13.20 -13.87

IOL Chem & Pharma Share Price

89.63 -1.53 (-1.68%)
20-Apr-2026 10:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.25
Dr. Reddys Lab 1235.85
Cipla 1236.25
Zydus Lifesciences 941.20
Lupin 2336.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×